261 related articles for article (PubMed ID: 9687335)
1. Increased shelf-life of fosphenytoin: solubilization of a degradant, phenytoin, through complexation with (SBE)7m-beta-CD.
Narisawa S; Stella VJ
J Pharm Sci; 1998 Aug; 87(8):926-30. PubMed ID: 9687335
[TBL] [Abstract][Full Text] [Related]
2. Cyclodextrin-catalyzed deacetylation of spironolactone is pH and cyclodextrin dependent.
Jarho P; Vander Velde D; Stella VJ
J Pharm Sci; 2000 Feb; 89(2):241-9. PubMed ID: 10688753
[TBL] [Abstract][Full Text] [Related]
3. Degradation of NSC-281612 (4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde), an experimental antineoplastic agent: effects of pH, solvent composition, (SBE)7m-beta-CD, and HP-beta-CD on stability.
Jumaa M; Chimilio L; Chinnaswamy S; Silchenko S; Stella VJ
J Pharm Sci; 2004 Mar; 93(3):532-9. PubMed ID: 14762892
[TBL] [Abstract][Full Text] [Related]
4. Effect of cyclodextrin charge on complexation of neutral and charged substrates: comparison of (SBE)7M-beta-CD to HP-beta-CD.
Zia V; Rajewski RA; Stella VJ
Pharm Res; 2001 May; 18(5):667-73. PubMed ID: 11465424
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of (SBE)7m-beta-CD and HP-beta-CD on the stability of two anti-neoplastic agents, melphalan and carmustine.
Ma DQ; Rajewski RA; Vander Velde D; Stella VJ
J Pharm Sci; 2000 Feb; 89(2):275-87. PubMed ID: 10688757
[TBL] [Abstract][Full Text] [Related]
6. Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-beta-cyclodextrin as both a solubilizing and an osmotic pump agent.
Okimoto K; Rajewski RA; Stella VJ
J Control Release; 1999 Mar; 58(1):29-38. PubMed ID: 10021487
[TBL] [Abstract][Full Text] [Related]
7. New injectable melphalan formulations utilizing (SBE)(7m)-beta-CD or HP-beta-CD.
Ma DQ; Rajewski RA; Stella VJ
Int J Pharm; 1999 Nov; 189(2):227-34. PubMed ID: 10536251
[TBL] [Abstract][Full Text] [Related]
8. Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-beta-cyclodextrin as a solubilizing agent.
Rao VM; Haslam JL; Stella VJ
J Pharm Sci; 2001 Jul; 90(7):807-16. PubMed ID: 11458330
[TBL] [Abstract][Full Text] [Related]
9. Combined effect of SLS and (SBE)(7M)-beta-CD on the solubilization of NSC-639829.
Yang G; Jain N; Yalkowsky SH
Int J Pharm; 2004 Jan; 269(1):141-8. PubMed ID: 14698585
[TBL] [Abstract][Full Text] [Related]
10. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
Stojanov M; Nielsen HM; Larsen KL
Int J Pharm; 2012 Jan; 422(1-2):349-55. PubMed ID: 22027391
[TBL] [Abstract][Full Text] [Related]
11. Hydroxypropyl-beta-cyclodextrin increases the aqueous solubility and stability of pilocarpine prodrugs.
Jarho P; Urtti A; Järvinen T
Pharm Res; 1995 Sep; 12(9):1371-5. PubMed ID: 8570537
[TBL] [Abstract][Full Text] [Related]
12. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use.
Holvoet C; Heyden YV; Plaizier-Vercammen J
Pharmazie; 2005 Aug; 60(8):598-603. PubMed ID: 16124403
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.
Zheng Y; Haworth IS; Zuo Z; Chow MS; Chow AH
J Pharm Sci; 2005 May; 94(5):1079-89. PubMed ID: 15793810
[TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-beta-CD.
Okimoto K; Ohike A; Ibuki R; Aoki O; Ohnishi N; Irie T; Uekama K; Rajewski RA; Stella VJ
Pharm Res; 1999 Apr; 16(4):549-54. PubMed ID: 10227711
[TBL] [Abstract][Full Text] [Related]
15. Applicability of (SBE)7m-beta-CD in controlled-porosity osmotic pump tablets (OPTs).
Okimoto K; Tokunaga Y; Ibuki R; Irie T; Uekama K; Rajewski RA; Stella VJ
Int J Pharm; 2004 Nov; 286(1-2):81-8. PubMed ID: 15501004
[TBL] [Abstract][Full Text] [Related]
16. A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor.
Denora N; Potts BC; Stella VJ
J Pharm Sci; 2007 Aug; 96(8):2037-47. PubMed ID: 17554770
[TBL] [Abstract][Full Text] [Related]
17. Co-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms.
Savolainen J; Järvinen K; Taipale H; Jarho P; Loftsson T; Järvinen T
Pharm Res; 1998 Nov; 15(11):1696-701. PubMed ID: 9833990
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in-vitro release rate of fentanyl-cyclodextrin complexes for prolonged action in epidural analgesia.
Holvoet C; Plaizier-Vercammen J; Vander Heyden Y; Gabriëls M; Camu F
Int J Pharm; 2003 Oct; 265(1-2):13-26. PubMed ID: 14522114
[TBL] [Abstract][Full Text] [Related]
19. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
Koontz JL; Marcy JE
J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
[TBL] [Abstract][Full Text] [Related]
20. Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir.
Tirucherai GS; Mitra AK
AAPS PharmSciTech; 2003; 4(3):E45. PubMed ID: 14621977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
